Comprehensive loss Sample Clauses
Comprehensive loss. Balance at December 31, ------ ---------- -------- ------- -------- ------ -------- See accompanying notes F-5 YEARS ENDED DECEMBER 31, --------------------------------- 1999 1998 1997 --------- --------- CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES Net loss.................................................... $ (38,448) $ (18,356) $ (9,983) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization............................. 6,889 3,415 2,337 Amortization of deferred compensation..................... 365 183 101 Issuance of common stock for services..................... 798 -- -- Issuance of common stock and stock options in connection with licensing agreements............................... -- 284 600 Acquired in-process research and development.............. 9,890 -- -- Changes in assets and liabilities: Decrease (increase) in accounts receivable, other current assets, and other assets................................ (8,004) (876) 518 Increase (decrease) in accounts payable and accrued liabilities............................................. 12,724 (1,546) 7,443 Increase (decrease) in deferred revenue................... 452 (2,327) 3,963 --------- --------- Net cash (used in) provided by operating activities......... (15,334) (19,223) 4,979 CASH FLOWS USED IN INVESTING ACTIVITIES Acquisition of PulmoSpheres-Registered Trademark- --------- --------- --------- --------- --------- Net cash used in investing activities....................... (82,439) (6,500) (85,557) CASH FLOWS FROM FINANCING ACTIVITIES --------- --------- --------- Issuance of convertible subordinated debentures, net........ 104,806 -- -- Payments of loan and capital lease and obligations.......... (64) (181) (168) Proceeds from tenant improvement loan....................... -- -- 5,000 Issuance of common stock, net of issuance costs............. 1,545 36,716 71,282 --------- --------- Net cash provided by financing activities................... 106,287 36,535 76,114 --------- --------- Net increase (decrease) in cash and cash equivalents........ 8,514 10,812 (4,464) Cash and cash equivalents at beginning of year.............. 24,916 14,104 18,568 --------- --------- See accompanying notes F-6 INHALE THERAPEUTIC SYSTEMS, INC. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 1999 NOTE 1--ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ORGANIZATION AND BASIS OF PRESENTATION Inhale Therapeutic Systems, Inc. ("Inhale", the "Company") was ...
Comprehensive loss. The Company applies ASC 220, "Comprehensive Income", with respect to reporting and presentation of comprehensive loss. The comprehensive loss of the Company only comprises of net loss as the Company did not have any other comprehensive income item in the years ended December 31, 2009, 2010 and 2011, respectively.
Comprehensive loss. Balance at December 31, 1998....................... Issuance of common stock to Alliance...................
Comprehensive loss. Balance at December 31, 1997....................... Issuance of common stock in private placement, net of issuance costs of $1,997... Issuance of common stock and stock options in connection with licensing agreement... Common stock issued upon exercise of stock options....................
Comprehensive loss. The components of comprehensive loss consist of the following (in thousands): THREE MONTHS ENDED SIX MONTHS ENDED JUNE 30, JUNE 30, 2000 1999 2000 1999
Comprehensive loss. The following table reflects the calculation of comprehensive losses for the year ended December, 31, 2000, 1999, and 1998 (in thousands): 2000 1999 1998 ----------- ---------- ---------- Net loss applicable to common stockholders........................ $ (143,101) $ (64,999) $ (16,581) ----------- ---------- ---------- Other comprehensive loss: Foreign currency translation adjustments...................... (38) -- -- ----------- ---------- ---------- Comprehensive loss applicable to common stockholders................. $ (143,139) $ (64,999) $ (16,581) =========== ========== ==========
Comprehensive loss. $(2,887) ======= 6,720 -------- $(28,682) ======== 5. ACQUISITIONS NETWORK24 COMMUNICATIONS, INC. In February 2000, the Company acquired all of the outstanding common and preferred stock of Network24 Communications Inc. ("Network24") in exchange for 599,152 shares of Akamai common stock and $12.5 million in cash. Akamai also issued options and warrants exercisable for 195,862 shares of Akamai's common stock in exchange for all outstanding options and warrants exercisable for Network24 common stock. The value of the acquisition was approximately $198.2 million based on the fair value of the consideration paid plus direct acquisition costs. The acquisition has been accounted for using the purchase method. Accordingly, the results of operations of Network24 subsequent to February 10, 2000 have been included in Akamai's statement of operations for the three months ended March 31, 2000. Pro forma financial information combining the results of operations of Akamai and Network24 as if the acquisition had occurred at the beginning of the quarter ended March 31, 1999 and 2000 would not be significantly different than the reported actual amounts. INTERVU INC. In April 2000, the Company acquired all of the outstanding common and preferred stock of INTERVU Inc. ("INTERVU") in exchange for 9.9 million shares of Akamai common stock. Akamai also assumed options and warrants exercisable for
Comprehensive loss. Adjustment to conform ASTeX's year end....... 5,968 BALANCE AT DECEMBER 31, 2001................. ---------- 37,998,699 ---- 113 -------- 285,252 ------- 68,160 ------- -- Issuance of common stock from exercise of stock options and Employee Stock Purchase Plan........................................ 661,054 8,920 Tax benefit from exercise of stock options... Issuance of common stock for acquisition of businesses.................................. 12,700,000 1,648 282,341
Comprehensive loss. Comprehensive loss includes all changes in stockholders' equity (deficit) during the year except those resulting from capital transactions. Other comprehensive income represents foreign currency translation adjustments for all years presented. RECENT PRONOUNCEMENTS In December 1999, the United States Securities and Exchange Commission issued Staff Accounting Bulletin No. 101, "Revenue Recognition in Financial Statements" (SAB 101), which provides guidance on the recognition, presentation and disclosure of revenue in financial statements of all public registrants. The provisions of SAB 101 are effective for the Company's fourth quarter ending June 30, 2001. The Company has not determined the impact of SAB 101, if any, on the consolidated financial statements. In March 2000, the Financial Accounting Standards Board issued FASB Interpretation No. 44, "Accounting for Certain Transactions Involving Stock Compensation" (FIN No. 44). This statement is effective for certain transactions from December 15, 1998 and is to be applied commencing July 1, 2000. The Company believes its existing stock based compensation policies are in compliance with FIN No. 44 and therefore, the adoption of FIN No. 44 will have no material impact on the Company's financial condition, results of operations or cash flows. In March 2000, the Financial Accounting Standards Board issued EITF 00-2 "Accounting for Web Site Development Costs." EITF 00-2 will be effective for the Company's year end June 30, 2001. The Company does not expect that EITF 00-2 will have a material impact on its consolidated financial statements.
Comprehensive loss. The components of comprehensive loss consist of the following (in thousands): THREE MONTHS ENDED MARCH 31, ------------------ 2001 2000 ------- ------- Net loss................................................. $(3,407) $(5,032) Other comprehensive income (loss): Change in unrealized gain on forward exchange contracts........................................... (67) -- Change in unrealized gain (loss) on available-for-sale